Individualized Surgical Guidance in HCC-BDTT (NCT07483242) | Clinical Trial Compass
CompletedNot Applicable
Individualized Surgical Guidance in HCC-BDTT
China151 participantsStarted 2024-08-01
Plain-language summary
The Rboost causal model can identify patients who are most likely to benefit among HCC-BDTT patients. Adherence to the individualized recommendation improves survival. This data-driven tool offers vital support for precision surgical decision-making in this high-risk disease.
Who can participate
Age range
31 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pathologically confirmed HCC with BDTT;
* Absence of extrahepatic malignancies at the time of HCC diagnosis;
* Undergone R0 curative hepatectomy;
* No prior antitumor therapies, such as chemotherapy or immunotherapy, before surgery;
* Availability of preoperative imaging (CT or MRI) with standardized tumor evaluation.
Exclusion Criteria:
* Pathological findings indicating concurrent cholangiocarcinoma and HCC;
* Loss to follow-up, preventing outcome evaluation, or insufficient clinical data for analysis.
* Significant comorbidities (e.g., severe cardiac or renal failure) that could affect surgical outcomes.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Treatment Effects
Timeframe: 2025.09.01
Trial details
NCT IDNCT07483242
SponsorFirst Affiliated Hospital, Sun Yat-Sen University